Radiant Innovation

Radiant Innovation Earnings Yield

The Earnings Yield of Radiant Innovation (3373.TWO) as of Nov 4, 2026 is -7.15 %. In the previous year, Earnings Yield was -3.38 % — a change of 111.53% (lower).

Earnings Yield

-7.15 %

YoY

111.53%

Last updated:

Earnings Yield of Radiant Innovation is 2025 -7.15 % . Earnings Yield of Radiant Innovation was 2024 -3.38 % . It decreases by 111.53% lower compared to the previous year.

The Radiant Innovation Earnings Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Earnings Yield
Date
Earnings Yield
Jan 1, 2018
1.68 TWD
Jan 1, 2019
3.40 TWD
Jan 1, 2020
87.12 TWD
Jan 1, 2021
13.31 TWD
Jan 1, 2022
3.39 TWD
Jan 1, 2023
-5.77 TWD
Jan 1, 2024
-3.38 TWD
Jan 1, 2025
-7.15 TWD
The Radiant Innovation Earnings Yield history
YEAREarnings YieldYoY
-7.15 %+111.53%
-3.38 %-41.40%
-5.77 %-270.13%
3.39 %-74.51%
13.31 %-84.73%
87.12 %+2,459.79%
3.40 %+102.15%
1.68 %+7.11%
1.57 %-63.49%
4.31 %-48.17%
8.31 %+93.73%
4.29 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Radiant Innovation Stock analysis

What does Radiant Innovation do? Radiant Innovation Inc. generates revenue through the design, manufacture, and sale of infrared technology products. The company's main products include infrared temperature measurement instruments, ear temperature guns, frontal temperature guns, and other body temperature measurement products, alongside carbon dioxide detectors, infrared thermal imagers, and blood glucose dedicated chipsets. These products are distributed domestically and internationally across Asia, the Americas, Europe, and other regions. The primary buyers are healthcare providers, medical facilities, and electronic component distributors who require precise measurement tools and specialized components for health monitoring and diagnostics. The firm's product portfolio targets healthcare and industrial segments, with infrared thermal imagers used in building inspections and carbon dioxide detectors deployed in environmental monitoring. Blood glucose dedicated chipsets are supplied to medical device manufacturers for integration into diagnostic equipment. International distribution channels focus on regions like Asia, the Americas, and Europe, where demand for health-related measurement devices remains strong. Revenue streams are driven by direct sales to medical institutions, electronic component distributors, and industrial clients. The company's product lines serve both consumer-facing health monitoring applications and specialized industrial uses, with a strong emphasis on accuracy and reliability in temperature and gas detection technologies. Radiant Innovation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Radiant Innovation stock

Earnings Yield of Radiant Innovation is -7.15 % in 2025.

Earnings Yield of Radiant Innovation changed from -3.38 % to -7.15 %, representing a 111.53% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Earnings Yield Radiant Innovation since 2006 – with annual values, charts, and detailed analysis.

Earnings Yield is the inverse of the P/E ratio. It shows the percentage of each dollar invested that was earned by the company. Higher earnings yield indicates better value.

To evaluate Earnings Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Earnings Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Earnings Yield's Radiant Innovation with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Radiant Innovation

All Key Metrics — Radiant Innovation